Skip to main content
Normal View

Cancer Screening Programmes

Dáil Éireann Debate, Thursday - 18 October 2018

Thursday, 18 October 2018

Questions (236)

Alan Kelly

Question:

236. Deputy Alan Kelly asked the Minister for Health when the audit of CervicalCheck will recommence by the HSE; and his plans to ensure women who, chronologically and statistically based on previous smear analysis, need to have new smears carried out in a timely fashion do not have their future health outcomes potentially negatively affected by the fact they are now part of a larger number of smears in circumstances in which there are backlogs and some slides are going out of date in view of the commitment he gave to allow all women have a free smear test. [43086/18]

View answer

Written answers

Following the emergence of issues relating to CervicalCheck earlier this year, the audit process was paused pending the outcome of the two reviews established by Government.

The first of these was the report of the Scoping Inquiry into issues surrounding CervicalCheck. Dr Scally’s report was published on my Department's website on 12 September and includes 50 recommendations, all of which have been accepted by Government. These include two recommendations relating specifically to auditing cervical screening. Dr Scally recommends that common, robust and externally validated approaches to all aspects of audit should be developed across the screening services. He also advises that there should be two patient advocates involved in the oversight of clinical audit for the screening services. Both of these recommendations will be implemented.

I want to see audit of cervical screening recommence as soon as possible, but it must be done in the right way and in the robust way that Dr Scally recommends, and there is obviously some work required to ensure that happens.

In relation to the second query, on 1 May, following a Government Decision, I asked CervicalCheck to make the necessary arrangements to provide that any woman who had had a CervicalCheck smear test, and whose GP considered that they should have a further test, could access such a test without charge. This decision was taken considering the need to provide reassurance to women.

The HSE advises that CervicalCheck laboratory activity remains significantly above normal levels. This is a result both of out-of-cycle smears, and also increased uptake generally. This has impacted turnaround times for results of smear tests.

The HSE also advises that every effort is being made to ensure that tests are processed as quickly as possible, having regard to the high standards required for testing. This is a priority concern for my Department and the HSE. The recent agreements reached with the contracted labs includes arrangements to address the backlog in testing.

I think it is important to emphasise that smear tests are a screening and not a diagnostic process, and if any women is concerned or is experiencing any symptoms, she should consult with her GP.

Top
Share